Article Text

AB0796 Clinical picture of anti-jo-1 positive anti-synthetase syndrome at presentation and during follow-up
  1. E. Scorletti,
  2. L. Cavagna,
  3. R. Caporali,
  4. C. Fusetti,
  5. N. Boffini,
  6. C. Montecucco
  1. Department of Rheumatology, University and Irccs Foundation Policlinico S. Matteo, Pavia, Italy


Background Anti-synthetase syndrome (AS) is a connective tissue disease characterized by myositis, arthritis, interstitial lung disease (ILD) and the presence of anti-synthetase antibodies, mostly anti-Jo-1. Patients with an incomplete form of AS have been described; however it is not known whether and when these patients will develop a full-blown clinical picture during the course of the disease

Objectives To evaluate whether and how the clinical spectrum of patients with a diagnosis of incomplete AS changes during follow-up

Methods All patients with anti-Jo-1 positive AS followed at our Department from 1991 were retrospectively evaluated for clinical features at the time of diagnosis and during follow-up. All patients had been regularly followed at our department. Two patients died during follow-up (after 57 and 106 months), whereas two patients were lost to follow-up after 92 and 118 months. All the remaining patients had their last visit after August 2011. Anti-Jo-1 positivity was confirmed in stored frozen sera from all patients using EliA Jo-1 fluoroenzyme-immunoassay (Phadia 250 automatic instrumentation, Phadia GmbH, Freiburg, Germany)

Results For the purpose of this study, 18 patients (5 males/13 females) were analyzed. Median age at onset was 52.5 years (IQR 45-69) and median follow-up was 75 months (IQR 38-95). At the time of diagnosis, 8 patients (44%) had a complete form. The remaining 10 patients had an incomplete form; 5 had isolated arthritis, 3 arthritis and ILD, 1 arthritis and myositis and 1 had isolated ILD. At the last follow-up visit, a complete form of the disease was present in 14 patients (78%). Five patients with isolated arthritis developed both myositis and ILD within 3 months to 13 years, and 1 out of 3 patients with arthritis and ILD developed myositis after 2 years. Finally, the patient with isolated ILD developed arthritis after 21 months

Conclusions Clinical presentation of anti-Jo-1 AS is quite variable as only 44% of patients had a complete form at onset. In particular, myositis was present in 50% of the patients diagnosed at our department and ILD in 67%. A long and careful follow-up is mandatory in patients with incomplete syndrome as myositis and ILD may occur even very late during the course of the disease

Disclosure of Interest None Declared

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.